Pamwoyo wekugona kwedu kweR&D ichikwata chedu, boka rakasiyana revatsvagiri vanopfuura mazana maviri nevatatu, vanoumba 20.80% yevashandi vedu. Iri dziva rine tarenda revanhu haisi nhamba chete; inomiririra kunyunguduka kwemazano, hunyanzvi, uye vavariro. Tichishanda pamwe chete nemasangano anotungamira emudzimba uye ekunze kwenyika, takawedzera mahorizoni edu, tichiunza vanopfuura makumi maviri vakatanhamara venyanzvi dzehunyanzvi vanogovera chiono chedu cheramangwana rehutano.
Kuzvipira kwedu kuhunyanzvi hwekuvandudza zvinhu kunoratidzwawo mune yedu portfolio yakasimba yepfuma yehungwaru, tichiburitsa mazana maviri nemakumi manomwe nenomwe eChinese patents uye makumi matatu emvumo yepasi rose. Zviverengero izvi zvinopfuura zviitiko zvinokosha; ivo chiratidzo chakajeka chehutungamiriri hwedu uye mweya wekupayona muchikamu chepeptide. Kufambira mberi kwedu kwetekinoroji kunopupurirwazve nehunyanzvi hwedu hwekutanga tekinoroji yekugadzirwa kwakakura kwepeptide, iyo isingangokwidziri kushanda kwekugadzira asiwo inosimudzira kunaka kwezvigadzirwa zvedu, kuve nechokwadi kuti zvinosangana nezvinoda kusimba zvekudhura-kuita.
Hybio ndiani
Hybio Pharmaceutical Co., Ltd.,Zvitupa zvitsva zvemushonga
Zvibvumirano zvekiriniki
GMP zvitupa muChina, zvinofukidza gumi nematatu APIs, jekiseni uye yakasimba dosages
Zvitupa zvemvumo yepeptide yapera kugadzirwa
Overview
- YEKUTANGA yakanyorwa peptide mugadziri muChina. R&D, kugadzira uye kushambadzira kwekurapa peptide APIs, peptide-based drugs. 01
- PIPELINE yechirwere cheshuga mellitus, obstetrics uye gynecology, moyo, gastroenterology, immunology, neurology, uye skincare. 02
- US FDA/EU cGMP chiyero, yakasarudzika yekudzora uye mhando timu. 03
- STRONG network kufukidzwa kwekutengesa & kushambadzira pamusoro peChina mainland. Kupfuura makore gumi 'ruzivo mukusimudzira musika wepasi rose. 04
Tsika dzedu
Chiratidzo
Mission uye Tsika
Kubatsira Kwedu
Munyika iri kusimukira yemishonga yepeptide, Hybio Pharmaceutical inobatikana nekuzvipira kwakadzama mukutsvaga nekusimudzira (R&D) uye kuzvipira kusingazungunuke kune mhando.
Rwendo rwedu rwunokuchidzirwa nechido chekuvandudza, kutsvaga kwaita kuti tiise mari zvakanyanya mukuedza kwedu kweR&D, zvichiratidza yakakura 29.41% yemari yedu yekudzokera mukutsvagisa muQ1-3 2023 chete. Kuisa mari iyi chiratidzo chekutsunga kwedu kutungamira uye kutsanangura patsva zviyero zveindasitiri.
- Tsvakurudzo uye Kubudirira
- Quality System
Hunhu haungori chikamu chehurongwa hwedu hwekushanda; ndiwo musimboti wemaitiro edu ekugadzira. Nzvimbo dzedu dzekugadzira dzeActive Pharmaceutical Ingredients (API) uye Finished Dosage Forms (FDF) dzakabudirira kupfuura ongororo dzakaomarara mumisika yakaoma, kusanganisira China, US, Europe, neSouth Korea. Uku kutevedza kwepasirese kunosimbisa kuzvipira kwedu kutevedzera zviyero zvemhando yepamusoro, kuve nechokwadi chekuti zvigadzirwa zvedu zvakafanana nekunaka.
Yedu "mhando yekutanga" huzivi ndiyo hwaro pakavakirwa yedu yakazara yemhando yekutonga system. Iyi sisitimu haisi yekutevedzera chete; ndezvekupfuura zvinotarisirwa, kuve nechokwadi kuchengetedzwa, kushanda zvakanaka, uye kunaka kwemishonga yedu. Nezvitupa kubva kuUS cGMP, EU GMP, Korean GMP, uye mamwe mabhenji epasirese, hatisi kungotaura kuti tinokoshesa mhando; isu tiri kuzviratidza nechigadzirwa chese chinosiya zvivakwa zvedu. - Industrialization System
Kuwedzera kukwidziridza mupendero wedu wemakwikwi ndeye yedu yakazara peptide zvinodhaka maindasitiri system. Iyi sisitimu inosanganisa nzira dzepamusoro uye matekinoroji anokwenenzvera shanduko kubva mukutsvagisa kuenda kukutengesa-chiyero chekugadzira. Nekubatanidza hunyanzvi hwekugadzira masisitimu uye maitiro ekuchenesa, isu tinoona scalability yepeptides yedu, tichichengetedza iwo epamusoro mazinga emhando kubva mulabhu kuenda kumusika. Iyi isina musono maindasitiri maitiro anosimbisa kugona kwedu kukurumidza kuunza pasi peptide marapirwo kuvarwere, tichisimbisa kuzvipira kwedu kusimudzira hutano.
PaHybio, isu hatingogadziri peptide mishonga; tiri kuseta mabenchmark matsva ezvazvinoreva kuve pamharadzano yehunyanzvi uye mhando. Ongorora maitiro ane kuzvipira kwedu, shungu, uye kugona kwedu pahutano, kuumba ramangwana apo kurapwa kwepamusoro uye kutarisirwa kwemhando yepamusoro kunofambidzana.
Kuzivikanwa
“Munzvimbo yezviroto ndimo mune mukana webudiriro dzinoshamisa. Kana isu tikatsunga kurota nekuita nechivimbo, zvisingagoneki zvinogoneka. "
State & Local Joint Engineering Laboratory yePeptide Drug uye Guangdong Engineering R&D Center yePeptide Drug
R&D Center yeHybio Pharmaceutical yakavambwa muna 2003. Mushure meanopfuura makore gumi ebudiriro, yakatevedzana yakasarudzwa seGuangdong Provincial Engineering Technology Research and Development Center yePeptide Drugs neGuangdong Provincial Dhipatimendi reSainzi neTekinoroji, uye National and Local Joint Engineering Laboratory yePeptide Drugs neNational Development and Reform Commission.
